Chimeric antigen receptor (CAR) natural killer (NK) cell therapy that targets the CD19 antigen has yielded promising results for patients with a range of B-cell malignancies.
Researchers from The University of Texas MD Anderson Cancer Center, USA,...
1 year ago
People in England with sickle cell disorder and thalassaemia will have NHS access to the world’s first blood group genotyping test, it has been announced.
NHS England said the testing will transform care for patients living with sickle cell disord...
1 year ago
